Table 4 Multivariate analysis of the effect of treatment on overall survival in different population
Treatment | Population | HRa (95% CI) | P-value |
|---|---|---|---|
Surgery (yes vs. no) | all patients | 0.476 (0.250–0.904) | 0.023 |
Adjuvant chemotherapy (yes vs. no) | post-operative patients | 0.521 (0.284–0.955) | 0.035 |
Neoadjuvant chemotherapy (yes vs. no) | stage II or III patients | 1.430 (0.791–2.587) | 0.237 |
Radiotherapy (yes vs. no) | lymph node+ patients | 0.733 (0.415–1.295) | 0.285 |
Endocrine therapy (yes vs. no) | HR+ patients | 0.440 (0.261–0.741) | 0.002 |
Targeted therapy (yes vs. no) | HER2+ patients | 0.168 (0.029–0.958) | 0.045 |